Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Retained Earnings (2016 - 2025)

Historic Retained Earnings for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to -$87.2 million.

  • BioCorRx's Retained Earnings fell 628.6% to -$87.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$87.2 million, marking a year-over-year decrease of 628.6%. This contributed to the annual value of -$83.2 million for FY2024, which is 653.77% down from last year.
  • Latest data reveals that BioCorRx reported Retained Earnings of -$87.2 million as of Q3 2025, which was down 628.6% from -$85.3 million recorded in Q2 2025.
  • BioCorRx's 5-year Retained Earnings high stood at -$66.3 million for Q1 2021, and its period low was -$87.2 million during Q3 2025.
  • For the 5-year period, BioCorRx's Retained Earnings averaged around -$76.4 million, with its median value being -$76.3 million (2023).
  • As far as peak fluctuations go, BioCorRx's Retained Earnings tumbled by 333970.35% in 2021, and later tumbled by 506.74% in 2023.
  • BioCorRx's Retained Earnings (Quarter) stood at -$70.0 million in 2021, then decreased by 6.24% to -$74.3 million in 2022, then fell by 5.07% to -$78.1 million in 2023, then dropped by 6.54% to -$83.2 million in 2024, then dropped by 4.8% to -$87.2 million in 2025.
  • Its Retained Earnings stands at -$87.2 million for Q3 2025, versus -$85.3 million for Q2 2025 and -$84.1 million for Q1 2025.